Reports (1326)

  • Biomedical Research, Clinical Trials as Topic methods, Randomized Controlled Trials as Topic methods, United States
    Review of NASA's Evidence Reports on Human Health Risks: 2013 Letter Report

    National Academies Press (US)

    Get Access
  • Clinical Trials as Topic, Insurance, Health, Reimbursement, Medicare , United States,
    Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Clinical Trials as Topic standards, Health Policy, Neoplasms therapy, Patient Care standards, United States
    Chromium, Nickel and Welding.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic, Communication Barriers, Ethnic Groups, Healthcare Disparities, Minority Groups, Patient Selection, United States, Women
    Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Clinical Trials as Topic, standards , Decision Making, Quality Control, Research Design,
    Hormonal Contraception and Post-menopausal Hormonal Therapy.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic, standards, Ethics, Research, Human Experimentation, standards , Neoplasms, Patient Rights, Research Subjects, United States,
    Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Clinical Laboratory Techniques economics, Medicare economics, Prospective Payment System, United States
    Human Papillomaviruses.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Protocols, Human Experimentation, Patient Rights, Safety
    Inorganic and Organic Lead Compounds.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Clinical Trials as Topic, Information Dissemination
    Ionizing Radiation, Part 1: X- and Gamma Radiation, and Neutrons.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Genetics, Medical , Health Policy, Risk Factors, United States,
    Ionizing Radiation, Part 2: Some Internally Deposited Radionuclides.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Biomedical Research, Neurodegenerative Diseases, Research Design
    Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Communicable Diseases, epidemiology , Datasets as Topic, Global Health, Population Surveillance,
    Silica, Some Silicates, Coal Dust and para-Aramid Fibrils.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Communicable Disease Control, methods , Disease Outbreaks, prevention & control, Health Communication, methods , Mass Media, statistics & numerical data, United States,
    Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Arthritis, Rheumatoid, therapy , Chronic Disease, therapy, Delivery of Health Care, trends, Lupus Erythematosus, Systemic, therapy, Outcome Assessment, Health Care, United States,
    Solar and Ultraviolet Radiation.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Communicable Disease Control, trends , Global Health, Health Policy, Immunization, trends , Virus Diseases, prevention & control ,
    Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Aggression, Disease Outbreaks, Evidence-Based Practice, Global Health, Violence, prevention & control ,
    Some Chemicals Used as Solvents and in Polymer Manufacture.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Delivery of Health Care, standards , Disease, classification , Quality of Health Care, United States,
    Some Drinking-water Disinfectants and Contaminants, including Arsenic.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Communicable Disease Control, trends , Health Workforce, Public Health, education,
    Some Flame Retardants and Textile Chemicals, and Exposures in the Textile Manufacturing Industry.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Bioterrorism, prevention & control, Communicable Disease Control, Disaster Planning , Disasters, Health Policy, Public Health Administration, Security Measures , United States,
    Some Industrial Chemicals.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Disease Susceptibility , Environmental Exposure, Sex Factors , Women's Health,
    Some Nanomaterials and Some Fibres.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Communicable Disease Control, Global Burden of Disease, Global Health , International Cooperation, Internationality, United States,
    Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Arthropod Vectors , Communicable Diseases, transmission, Global Health , Zoonoses, transmission,
    Some Organophosphate Insecticides and Herbicides.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Disease Outbreaks, prevention & control , Global Health, Health Planning, organization & administration,
    Some Pharmaceutical Drugs.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Communicable Disease Control , Disease Outbreaks, prevention & control , Global Health, International Cooperation, Risk Factors,
    Tobacco Smoke and Involuntary Smoking.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Age Factors, Occupational Diseases, prevention & control , Occupational Health, United States,
    Trichloroethylene, Tetrachloroethylene, and Some Other Chlorinated Agents.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Policy, Immune System Diseases, etiology, Immunization Schedule, Immunization, adverse effects , Infant, Safety, United States,
    Welding, molybdenum trioxide, and indium tin oxide.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Policy, Immune System Diseases, etiology, Immunization Schedule, Immunization, adverse effects , Infant, Safety, United States,
    Wood Dust and Formaldehyde.

    IARC Working Group on the Evaluation of Carcinogenic Risk to Humans

    Get Access
  • Chronic Disease, Delivery of Health Care, Integrated methods, Health Policy, Social Determinants of Health, Social Work, United States
    The Health Consequences of Smoking: A Report of the Surgeon General.

    Centers for Disease Control and Prevention (US)

    Get Access
  • Mass Screening economics, Medicare economics, Preventive Health Services economics, Thyroid Diseases prevention & control, United States
    A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension.

    National Academies Press (US)

    Get Access
  • Africa South of the Sahara, Healthcare Disparities, Mental Disorders therapy, Nervous System Diseases therapy, Quality of Health Care organization & administration, Rural Health Services organization & administration, Substance-Related Disorders t
    A Proposed Framework for Integration of Quality Performance Measures for Health Literacy, Cultural Competence, and Language Access Services: Proceedings of a Workshop.

    National Academies Press (US)

    Get Access

Your Feedback